GlucoModicum today announced positive outcomes from a clinical performance study of its needle-free continuous glucose ...

Lifecare said on social media that it completed a significant milestone in the development of its continuous glucose monitor ...

Ypsomed announced today that Chinese regulatory authorities approved the a dual GCP/GLP-1 drug delivered using its ...

While many systems already pair continuous glucose monitors (CGMs) and insulin pumps, PharmaSens and SiBionics may have ...

One of the leaders in continuous glucose monitoring (CGM) technology, Dexcom (Nadsaq:DXCM) continues to expand its ...

Senseonics (NYSE:SENS) has offered some insight into its plans for its next-generation implantable continuous glucose ...

BTIG analysts said today that MiniMed, the Medtronic diabetes business, has some significant pipeline updates.

It's been a busy couple of years for Tandem Diabetes Care (Nasdaq:TNDM) and it doesn't look like slowing down any time soon.

Dexcom (Nasdaq:DXCM) has shared a new report highlighting access and attitudes toward type 2 diabetes in the U.S.

Additionally, Insulet shared that it has two planned clinical trials for new algorithms for its platforms. One involves ...